We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+16.33%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.37B
AUM Growth
+$227M
Cap. Flow
-$5.81M
Cap. Flow %
-0.25%
Top 10 Hldgs %
19.78%
Holding
359
New
114
Increased
58
Reduced
128
Closed
21

Sector Composition

Rank Sector Weight
1 Healthcare 21.26%
2 Consumer Discretionary 16.72%
3 Industrials 15.68%
4 Technology 14.21%
5 Consumer Staples 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHTH icon
76
eHealth
EHTH
$47.3M
$13.1M 0.55%
136,489
-59,405
-30% -$4.61M
BWIN
77
Baldwin Insurance Group
BWIN
$2.66B
$12.9M 0.55%
+806,628
New +$12.9M
MNR
78
DELISTED
Monmouth Real Estate Investment Corp
MNR
$12.9M 0.54%
888,491
-36,800
-4% -$544K
ALRM icon
79
Alarm.com
ALRM
$2.63B
$12.8M 0.54%
298,859
-1,090
-0.4% -$49.1K
URBN icon
80
Urban Outfitters
URBN
$6.25B
$12.7M 0.54%
458,699
+82,440
+22% +$2.29M
CCNE icon
81
CNB Financial Corp
CCNE
$1.02B
$12.7M 0.54%
388,113
ECVT icon
82
Ecovyst
ECVT
$1.41B
$12.6M 0.53%
732,211
-1,880
-0.3% -$30.1K
MMSI icon
83
Merit Medical Systems
MMSI
$4.41B
$12.6M 0.53%
402,782
-6,470
-2% -$185K
NVEE
84
DELISTED
NV5 Global
NVEE
$12.4M 0.52%
979,992
+9,636
+1% +$140K
NFE icon
85
New Fortress Energy
NFE
$102M
$12.3M 0.52%
781,760
-8,260
-1% -$137K
PTLA
86
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$12M 0.51%
500,974
-490
-0.1% -$13.5K
VNOM icon
87
Viper Energy
VNOM
$8.66B
$11.5M 0.49%
467,333
-2,712
-0.6% -$68K
REPL icon
88
Replimune Group
REPL
$859M
$11.4M 0.48%
793,594
+64,704
+9% +$932K
ACA icon
89
Arcosa
ACA
$7.12B
$10.7M 0.45%
+239,921
New +$9.23M
ILPT
90
Industrial Logistics Properties Trust
ILPT
$591M
$10.7M 0.45%
475,203
-49,577
-9% -$1.06M
CHUY
91
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$10.3M 0.43%
395,640
-1,015
-0.3% -$26.3K
STAG icon
92
STAG Industrial
STAG
$7.97B
$10.2M 0.43%
+323,782
New +$9.93M
VCEL icon
93
Vericel Corp
VCEL
$2.38B
$10.2M 0.43%
585,769
-171,020
-23% -$2.91M
KPTI icon
94
Karyopharm Therapeutics
KPTI
$216M
$9.61M 0.41%
33,417
-66,355
-67% -$14.4M
ADC icon
95
Agree Realty
ADC
$9.74B
$9.38M 0.4%
+133,710
New +$9.86M
OYST
96
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$9.14M 0.39%
+374,004
New +$6.56M
ASMB icon
97
Assembly Biosciences
ASMB
$531M
$8.92M 0.38%
36,315
-86
-0.2% -$15.8K
EVER icon
98
EverQuote
EVER
$925M
$8.86M 0.37%
257,930
+144,490
+127% +$4.03M
VREX icon
99
Varex Imaging
VREX
$445M
$8.78M 0.37%
294,546
-1,970
-0.7% -$58.8K
TPC
100
Tutor Perini Cor
TPC
$4.14B
$8.68M 0.37%
675,082
-6,224
-0.9% -$95.9K

Similar funds

Emerald Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Emerald Advisers held 359 positions worth $2.37B, up 11% from $2.14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2019 filing shows 114 new, 58 increased, 128 reduced and 21 closed positions. Its largest new stake was BellRing Brands: 1,634,376 shares worth $34.8M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $33M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Emerald Advisers's largest Q4 2019 buy was BellRing Brands: 1,634,376 shares worth $34.8M.
  • Emerald Advisers added most to Perficient Inc in Q4 2019, an estimated $15.7M increase.
  • Emerald Advisers's biggest Q4 2019 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $33M.
  • Emerald Advisers fully exited Arena Pharmaceuticals Inc in Q4 2019, selling an estimated $13.2M.
  • Emerald Advisers's ten largest holdings make up 20% of its $2.37B portfolio in Q4 2019.
  • Emerald Advisers opened 114 new positions and closed 21 in Q4 2019.
  • Emerald Advisers's portfolio value rose 11% quarter-over-quarter to $2.37B.

Based on Emerald Advisers's 13F filing for Q4 2019, filed 29 Jan 2020.